We are live on ! Find out more
CAG

Crestwood Advisors Group Portfolio holdings

AUM $5.94B
1-Year Est. Return 18.44%
This Fund
S&P 500
This Quarter Est. Return
+21.39%
1 Year Est. Return
+18.44%
3 Year Est. Return
+65.91%
5 Year Est. Return
+80.01%
10 Year Est. Return
+299.27%
AUM
$2.5B
AUM Growth
+$482M
Cap. Flow
+$84.9M
Cap. Flow %
3.4%
Top 10 Hldgs %
30.71%
Holding
250
New
26
Increased
102
Reduced
86
Closed
11

Sector Composition

Rank Sector Weight
1 Technology 21.37%
2 Financials 15.24%
3 Healthcare 10.98%
4 Consumer Discretionary 7.31%
5 Communication Services 7.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
META icon
26
Meta Platforms (Facebook)
META
$1.51T
$32.1M 1.29%
141,336
-16,374
-10% -$3.42M
SLY
27
DELISTED
SPDR S&P 600 Small Cap ETF (based on S&P SmallCap 600 Index--symbol SML)
SLY
$32M 1.28%
541,536
-2,172
-0.4% -$119K
EFA icon
28
iShares MSCI EAFE ETF
EFA
$76.8B
$30.6M 1.22%
502,166
-69,483
-12% -$4.02M
IBB icon
29
iShares Biotechnology ETF
IBB
$9.55B
$30.3M 1.21%
221,340
+998
+0.5% +$127K
PEP icon
30
PepsiCo
PEP
$195B
$29.3M 1.17%
221,156
+8,234
+4% +$1.09M
JPM icon
31
JPMorgan Chase
JPM
$950B
$29.1M 1.17%
309,645
-1,198
-0.4% -$114K
SYK icon
32
Stryker
SYK
$133B
$28.7M 1.15%
159,358
+7,347
+5% +$1.36M
MDT icon
33
Medtronic
MDT
$111B
$28.3M 1.13%
308,348
+10,613
+4% +$1.02M
USMV icon
34
iShares MSCI USA Min Vol Factor ETF
USMV
$23.7B
$26.9M 1.08%
443,892
+13,973
+3% +$829K
CVS icon
35
CVS Health
CVS
$140B
$26.4M 1.06%
406,920
+21,297
+6% +$1.34M
BKI
36
DELISTED
Black Knight, Inc. Common Stock
BKI
$26.2M 1.05%
361,298
-116
-0% -$8.22K
FTV icon
37
Fortive
FTV
$19.5B
$26.1M 1.04%
611,052
+2,651
+0.4% +$103K
ZTS icon
38
Zoetis
ZTS
$32.5B
$25.4M 1.02%
184,989
-11,034
-6% -$1.44M
COST icon
39
Costco
COST
$429B
$25.3M 1.01%
83,592
-179
-0.2% -$54.5K
TTD icon
40
Trade Desk
TTD
$8.89B
$25.2M 1.01%
620,290
+7,610
+1% +$229K
STZ icon
41
Constellation Brands
STZ
$22.5B
$24.9M 1%
142,093
+3,744
+3% +$624K
DIS icon
42
Walt Disney
DIS
$172B
$24.2M 0.97%
217,447
+14,785
+7% +$1.63M
FISV
43
Fiserv Inc
FISV
$28.9B
$23.1M 0.92%
236,366
+1,393
+0.6% +$140K
IJR icon
44
iShares Core S&P Small-Cap ETF
IJR
$110B
$21.8M 0.87%
319,083
+150,953
+90% +$9.53M
MRSH
45
Marsh
MRSH
$91.7B
$20M 0.8%
186,163
+8,269
+5% +$837K
PG icon
46
Procter & Gamble
PG
$347B
$19.8M 0.79%
165,186
+10,597
+7% +$1.24M
CL icon
47
Colgate-Palmolive
CL
$74.2B
$18.8M 0.75%
256,490
+6,434
+3% +$457K
JPIN icon
48
JPMorgan Diversified Return International Equity ETF
JPIN
$364M
$18.8M 0.75%
380,247
-289,328
-43% -$13.7M
BKNG icon
49
Booking.com
BKNG
$154B
$18.3M 0.73%
286,850
-4,975
-2% -$303K
HON icon
50
Honeywell
HON
$78.3B
$17.9M 0.72%
131,639
+9,495
+8% +$1.26M

Similar funds

Crestwood Advisors Group's Q2 2020 Portfolio in Review

As of Q2 2020, Crestwood Advisors Group held 250 positions worth $2.5B, up 24% from $2.02B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Crestwood Advisors Group deployed $84.9M of net new capital in Q2 2020, opening 26 new positions and adding to 102 existing holdings. Its largest new stake was Xylem: 208,372 shares worth $13.5M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares MSCI Emerging Markets ETF, an estimated $15.7M trimmed.

  • Crestwood Advisors Group's largest Q2 2020 buy was Xylem: 208,372 shares worth $13.5M.
  • Crestwood Advisors Group added most to iShares Core MSCI EAFE ETF in Q2 2020, an estimated $18.6M increase.
  • Crestwood Advisors Group's biggest Q2 2020 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $15.7M.
  • Crestwood Advisors Group fully exited Cue Biopharma in Q2 2020, selling an estimated $3.83M.
  • Crestwood Advisors Group's ten largest holdings make up 31% of its $2.5B portfolio in Q2 2020.
  • Crestwood Advisors Group opened 26 new positions and closed 11 in Q2 2020.
  • Crestwood Advisors Group's portfolio value rose 24% quarter-over-quarter to $2.5B.

Based on Crestwood Advisors Group's 13F filing for Q2 2020, filed 14 Aug 2020.